Related Experiment Video
Updated: Jul 10, 2026
qPCR Is a Sensitive and Rapid Method for Detection of Cytomegaloviral DNA in Formalin-fixed, Paraffin-embedded Biopsy Tissue
Published on: July 9, 2014
[Capture and detection of human cytomegalovirus (HCMV) IgM by a recombinant multi-epitope chimeric antigen]
Peng Sun1, Xing-Bao Sun, Peng Hu
1The Sixth People's Hospital of Shenzhen, Shenzhen 518054, China. sun0978@126.com
Insights
A new diagnostic method for detecting IgM antibodies against human cytomegalovirus (HCMV) shows 100% sensitivity and specificity. This antibody-capture ELISA (AC-ELISA) uses a novel recombinant antigen for accurate HCMV infection diagnosis.
Area of Science:
- Immunology
- Virology
- Biotechnology
Context:
- Human cytomegalovirus (HCMV) is a common viral infection, and timely diagnosis is crucial for patient management.
- Accurate detection of IgM antibodies is essential for identifying recent HCMV infections.
- Existing diagnostic methods may have limitations in sensitivity or specificity.
Purpose:
- To develop a highly sensitive and specific antibody-capture enzyme-linked immunosorbent assay (AC-ELISA) for detecting serum IgM against HCMV.
- To achieve this by genetically engineering and expressing a recombinant multi-epitope chimeric antigen of HCMV.
Summary:
- Dominant HCMV epitopes were identified using computer software.
- A recombinant multi-epitope chimeric antigen expression vector was constructed and expressed in E. coli.
- The purified antigen was used to develop an AC-ELISA, achieving 100% sensitivity and 100% specificity in detecting HCMV-specific IgM in patient sera.
Impact:
- The developed AC-ELISA demonstrates excellent diagnostic performance, comparable to commercial kits.
- This method offers a sensitive and specific tool for diagnosing HCMV infections.
- The recombinant antigen technology can be applied to improve other diagnostic assays.
Abstract:
To establish a sensitive and specific antibody-capture enzyme-linked immunosorbent assay (AC-ELISA) method to detect serum IgM against human cytomegalovirus (HCMV) by expressing a recombinant HCMV multi-epitope cheimeric antigen through genetic engineering. The dominant epitopes of HCMV were analyzed and selected by computer software A recombinant multi-epitope chimeric antigen expression vector including HCMV DNA was constructed, and transformed into E. coli BL21(DE3). The antigen was abundantly expressed, purified, and labeled by horseradish peroxidase for subsequent development of the AC-ELISA. Thirty validated positive sera and sixty-three validated negative sera were submitted for IgM detection by this recombinant antigen. The sensitivity and specificity of AC-ELISA with our recombinant antigen were both 100%. The sensitivity and specificity of this AC-ELISA diagnostic kit with the recombinant antigen are comparable to similar foreign commercial products.
